Funding for this research was provided by:
Health Technology Assessment Programme (13/115/48)
Received: 7 December 2018
Accepted: 2 May 2019
First Online: 3 June 2019
Ethics approval and consent to participate
: The study has been approved by the National Research Ethics Service committee, East of England—Cambridge South (ref.: 16/EE/0032). Clinical trial authorisation was given by the Medicines and Healthcare Products Regulatory Agency (MHRA). Written informed consent will be obtained from each participant prior to any study-related procedures.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.